Global White Matter Abnormalities in Schizophrenia: A Multisite Diffusion Tensor Imaging Study
White et al.
Schizophr Bull 2009;0:sbp088v2-sbp088.
ABSTRACT
| FULL TEXT
Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology
Fornito et al.
Schizophr Bull 2009;35:973-993.
ABSTRACT
| FULL TEXT
Reinforcement Ambiguity and Novelty Do Not Account for Transitive Inference Deficits in Schizophrenia
Coleman et al.
Schizophr Bull 2009;0:sbp039v1-sbp039.
ABSTRACT
| FULL TEXT
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
Stephan et al.
Schizophr Bull 2009;35:509-527.
ABSTRACT
| FULL TEXT
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Lieberman et al.
Pharmacol. Rev. 2008;60:358-403.
ABSTRACT
| FULL TEXT
Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
Harrison et al.
J Psychopharmacol 2008;22:308-322.
ABSTRACT
Evidence for Impaired Long-Term Potentiation in Schizophrenia and Its Relationship to Motor Skill Leaning
Frantseva et al.
Cereb Cortex 2008;18:990-996.
ABSTRACT
| FULL TEXT
Schizophrenia: Moving Beyond Monoamine Antagonists
Conn et al.
Mol. Interv. 2008;8:99-107.
ABSTRACT
| FULL TEXT
Dysfunctional Neural Plasticity in Patients With Schizophrenia
Daskalakis et al.
Arch Gen Psychiatry 2008;65:378-385.
ABSTRACT
| FULL TEXT
Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study
Deakin et al.
Arch Gen Psychiatry 2008;65:154-164.
ABSTRACT
| FULL TEXT
NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons
Homayoun and Moghaddam
J. Neurosci. 2007;27:11496-11500.
ABSTRACT
| FULL TEXT
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
THEBERGE et al.
Br. J. Psychiatry 2007;191:325-334.
ABSTRACT
| FULL TEXT
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions
Corlett et al.
Brain 2007;130:2387-2400.
ABSTRACT
| FULL TEXT
Are Anticorrelated Networks in the Brain Relevant to Schizophrenia?
Williamson
Schizophr Bull 2007;33:994-1003.
ABSTRACT
| FULL TEXT
Alternating and Postictal Psychoses: Review and a Unifying Hypothesis
Sachdev
Schizophr Bull 2007;33:1029-1037.
ABSTRACT
| FULL TEXT
Spontaneous Low-Frequency Fluctuations in the BOLD Signal in Schizophrenic Patients: Anomalies in the Default Network
Bluhm et al.
Schizophr Bull 2007;33:1004-1012.
ABSTRACT
| FULL TEXT
Why is D-serine nephrotoxic and {alpha}-aminoisobutyric acid protective?
Krug et al.
Am. J. Physiol. Renal Physiol. 2007;293:F382-F390.
ABSTRACT
| FULL TEXT
Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review
Stone et al.
J Psychopharmacol 2007;21:440-452.
ABSTRACT
Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen?
Rabiner
J Psychopharmacol 2007;21:253-258.
ABSTRACT
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
Large
J Psychopharmacol 2007;21:283-301.
ABSTRACT
Progressive and Interrelated Functional and Structural Evidence of Post-Onset Brain Reduction in Schizophrenia
Salisbury et al.
Arch Gen Psychiatry 2007;64:521-529.
ABSTRACT
| FULL TEXT
Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments
Butler et al.
Brain 2007;130:417-430.
ABSTRACT
| FULL TEXT
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia
Law et al.
Hum Mol Genet 2007;16:129-141.
ABSTRACT
| FULL TEXT
Fyn Is Required for Haloperidol-induced Catalepsy in Mice
Hattori et al.
J. Biol. Chem. 2006;281:7129-7135.
ABSTRACT
| FULL TEXT
A Specific Role for NR2A-Containing NMDA Receptors in the Maintenance of Parvalbumin and GAD67 Immunoreactivity in Cultured Interneurons
Kinney et al.
J. Neurosci. 2006;26:1604-1615.
ABSTRACT
| FULL TEXT
An Investigation of the Efficacy of Mood Stabilizers in Rodent Models of Prepulse Inhibition
Ong et al.
J. Pharmacol. Exp. Ther. 2005;315:1163-1171.
ABSTRACT
| FULL TEXT
Long-Lasting Impairment of Associative Learning Is Correlated with a Dysfunction of N-Methyl-D-aspartate-Extracellular Signaling-Regulated Kinase Signaling in Mice after Withdrawal from Repeated Administration of Phencyclidine
Enomoto et al.
Mol. Pharmacol. 2005;68:1765-1774.
ABSTRACT
| FULL TEXT
Perioperative Management for Chronic Schizophrenic Patients
Kudoh
Anesth. Analg. 2005;101:1867-1872.
ABSTRACT
| FULL TEXT
Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment
Yang and Chen
Neuroscientist 2005;11:452-470.
ABSTRACT
Ketamine Disrupts Frontal and Hippocampal Contribution to Encoding and Retrieval of Episodic Memory: An fMRI Study
Honey et al.
Cereb Cortex 2005;15:749-759.
ABSTRACT
| FULL TEXT
Early-Stage Visual Processing and Cortical Amplification Deficits in Schizophrenia
Butler et al.
Arch Gen Psychiatry 2005;62:495-504.
ABSTRACT
| FULL TEXT
Activation of Metabotropic Glutamate 2/3 Receptors Reverses the Effects of NMDA Receptor Hypofunction on Prefrontal Cortex Unit Activity in Awake Rats
Homayoun et al.
J. Neurophysiol. 2005;93:1989-2001.
ABSTRACT
| FULL TEXT
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Lieberman et al.
Arch Gen Psychiatry 2005;62:361-370.
ABSTRACT
| FULL TEXT
Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study
Rowland et al.
Am. J. Psychiatry 2005;162:394-396.
ABSTRACT
| FULL TEXT
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos et al.
Br. J. Psychiatry 2005;186:26-31.
ABSTRACT
| FULL TEXT
Density of Glutamic Acid Decarboxylase 67 Messenger RNA-Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Woo et al.
Arch Gen Psychiatry 2004;61:649-657.
ABSTRACT
| FULL TEXT
3-T Proton MRS Investigation of Glutamate and Glutamine in Adolescents at High Genetic Risk for Schizophrenia
Tibbo et al.
Am. J. Psychiatry 2004;161:1116-1118.
ABSTRACT
| FULL TEXT
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
Jackson et al.
Proc. Natl. Acad. Sci. USA 2004;101:8467-8472.
ABSTRACT
| FULL TEXT
Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors
Pei et al.
J. Neurosci. 2004;24:1149-1158.
ABSTRACT
| FULL TEXT
Glutamate and Glutamine in the Anterior Cingulate and Thalamus of Medicated Patients With Chronic Schizophrenia and Healthy Comparison Subjects Measured With 4.0-T Proton MRS
Theberge et al.
Am. J. Psychiatry 2003;160:2231-2233.
ABSTRACT
| FULL TEXT
HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease
Clarimon et al.
J Geriatr Psychiatry Neurol 2003;16:146-150.
ABSTRACT
Decreased Serum Levels of D-Serine in Patients With Schizophrenia: Evidence in Support of the N-Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia
Hashimoto et al.
Arch Gen Psychiatry 2003;60:572-576.
ABSTRACT
| FULL TEXT
Chronic Administration of Haloperidol and Olanzapine Attenuates Ketamine-Induced Brain Metabolic Activation
Duncan et al.
J. Pharmacol. Exp. Ther. 2003;305:999-1005.
ABSTRACT
| FULL TEXT
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis et al.
Arch Gen Psychiatry 2003;60:443-456.
ABSTRACT
| FULL TEXT
D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons
Martina et al.
J. Physiol. 2003;548:411-423.
ABSTRACT
| FULL TEXT
Untreated Initial Psychosis: Relation to Cognitive Deficits and Brain Morphology in First-Episode Schizophrenia
Ho et al.
Am. J. Psychiatry 2003;160:142-148.
ABSTRACT
| FULL TEXT
The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat
Abdul-Monim et al.
J Psychopharmacol 2003;17:57-66.
ABSTRACT
Blockade of Phencyclidine-Induced Cortical Apoptosis and Deficits in Prepulse Inhibition by M40403, a Superoxide Dismutase Mimetic
Wang et al.
J. Pharmacol. Exp. Ther. 2003;304:266-271.
ABSTRACT
| FULL TEXT
The Group II Metabotropic Glutamate Receptor Agonist (-)-2-Oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and Clozapine Reverse Phencyclidine-Induced Behaviors in Monoamine-Depleted Rats
Swanson and Schoepp
J. Pharmacol. Exp. Ther. 2002;303:919-927.
ABSTRACT
| FULL TEXT
Glutamate and Glutamine Measured With 4.0 T Proton MRS in Never-Treated Patients With Schizophrenia and Healthy Volunteers
Theberge et al.
Am. J. Psychiatry 2002;159:1944-1946.
ABSTRACT
| FULL TEXT
Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study
Cahn et al.
Arch Gen Psychiatry 2002;59:1002-1010.
ABSTRACT
| FULL TEXT
Transcranial Magnetic Stimulation: A New Investigational and Treatment Tool in Psychiatry
Daskalakis et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:406-415.
ABSTRACT
| FULL TEXT
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
Chumakov et al.
Proc. Natl. Acad. Sci. USA 2002;99:13675-13680.
ABSTRACT
| FULL TEXT
Mismatch Negativity in Chronic Schizophrenia and First-Episode Schizophrenia
Salisbury et al.
Arch Gen Psychiatry 2002;59:686-694.
ABSTRACT
| FULL TEXT
Ontogeny of the N-Methyl-D-Aspartate (NMDA) Receptor System and Susceptibility to Neurotoxicity
Haberny et al.
Toxicol Sci 2002;68:9-17.
ABSTRACT
| FULL TEXT
Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic Patients
Gluck et al.
Am. J. Psychiatry 2002;159:1165-1173.
ABSTRACT
| FULL TEXT
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry: What Is Happening in the Schizophrenic Brain?
Weinberger and McClure
Arch Gen Psychiatry 2002;59:553-558.
FULL TEXT
Is NMDA Receptor Hypofunction in Schizophrenia Associated With a Primary Hyperglutamatergic State?
Shim et al.
Arch Gen Psychiatry 2002;59:466-468.
FULL TEXT
NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: A Potential Mechanism of Neurotoxicity
Li et al.
J. Neurosci. 2002;22:3070-3080.
ABSTRACT
| FULL TEXT
ALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine Transporter
Atkinson et al.
Mol. Pharmacol. 2001;60:1414-1420.
ABSTRACT
| FULL TEXT
Pharmacological Characterization of Locomotor Sensitization Induced by Chronic Phencyclidine Administration
Phillips et al.
J. Pharmacol. Exp. Ther. 2001;296:905-913.
ABSTRACT
| FULL TEXT
Progressive Brain Volume Changes and the Clinical Course of Schizophrenia in Men: A Longitudinal Magnetic Resonance Imaging Study
Mathalon et al.
Arch Gen Psychiatry 2001;58:148-157.
ABSTRACT
| FULL TEXT
Deficits in Auditory and Visual Context-Dependent Processing in Schizophrenia: Defining the Pattern
Javitt et al.
Arch Gen Psychiatry 2000;57:1131-1137.
ABSTRACT
| FULL TEXT
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia
Umbricht et al.
Arch Gen Psychiatry 2000;57:1139-1147.
ABSTRACT
| FULL TEXT
Transplanted Neuroblasts Differentiate Appropriately into Projection Neurons with Correct Neurotransmitter and Receptor Phenotype in Neocortex Undergoing Targeted Projection Neuron Degeneration
Shin et al.
J. Neurosci. 2000;20:7404-7416.
ABSTRACT
| FULL TEXT
From the Cover: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
Abi-Dargham et al.
Proc. Natl. Acad. Sci. USA 2000;97:8104-8109.
ABSTRACT
| FULL TEXT
Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
McGlashan and Hoffman
Arch Gen Psychiatry 2000;57:637-648.
ABSTRACT
| FULL TEXT
Is There a Neuropathology of Schizophrenia? Recent Findings Converge on Altered Thalamic-Prefrontal Cortical Connectivity
Lewis
Neuroscientist 2000;6:208-218.
ABSTRACT
Comparison of the Effects of Clozapine, Risperidone, and Olanzapine on Ketamine-Induced Alterations in Regional Brain Metabolism
Duncan et al.
J. Pharmacol. Exp. Ther. 2000;293:8-14.
ABSTRACT
| FULL TEXT
Structural Abnormalities of Subicular Dendrites in Subjects With Schizophrenia and Mood Disorders: Preliminary Findings
Rosoklija et al.
Arch Gen Psychiatry 2000;57:349-356.
ABSTRACT
| FULL TEXT
Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists
Anand et al.
Arch Gen Psychiatry 2000;57:270-276.
ABSTRACT
| FULL TEXT
Characterization of MK-801-Induced Behavior as a Putative Rat Model of Psychosis
Andiné et al.
J. Pharmacol. Exp. Ther. 1999;290:1393-1408.
ABSTRACT
| FULL TEXT
Clozapine, But Not Haloperidol, Prevents the Functional Hyperactivity of N-Methyl-D-Aspartate Receptors in Rat Cortical Neurons Induced by Subchronic Administration of Phencyclidine
Arvanov and Wang
J. Pharmacol. Exp. Ther. 1999;289:1000-1006.
ABSTRACT
| FULL TEXT
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Robinson et al.
Am. J. Psychiatry 1999;156:544-549.
ABSTRACT
| FULL TEXT
The neuropathology of schizophrenia: A critical review of the data and their interpretation
Harrison
Brain 1999;122:593-624.
ABSTRACT
| FULL TEXT
Dopamine Selectively Inhibits the Direct Cortical Pathway to the CA1 Hippocampal Region
Otmakhova and Lisman
J. Neurosci. 1999;19:1437-1445.
ABSTRACT
| FULL TEXT
Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis
Sanger et al.
Am. J. Psychiatry 1999;156:79-87.
ABSTRACT
| FULL TEXT
Glycine Agonists: What Can They Teach Us About Schizophrenia?
Farber et al.
Arch Gen Psychiatry 1999;56:13-17.
FULL TEXT
A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia
Goff et al.
Arch Gen Psychiatry 1999;56:21-27.
ABSTRACT
| FULL TEXT
Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia
Heresco-Levy et al.
Arch Gen Psychiatry 1999;56:29-36.
ABSTRACT
| FULL TEXT
A decrease of reelin expression as a putative vulnerability factor in schizophrenia
Impagnatiello et al.
Proc. Natl. Acad. Sci. USA 1998;95:15718-15723.
ABSTRACT
| FULL TEXT
Modulation of N-methyl-D-aspartate receptor function by glycine transport
Bergeron et al.
Proc. Natl. Acad. Sci. USA 1998;95:15730-15734.
ABSTRACT
| FULL TEXT
Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma -amino butyrate type A receptor in prefrontal cortex of schizophrenics
Huntsman et al.
Proc. Natl. Acad. Sci. USA 1998;95:15066-15071.
ABSTRACT
| FULL TEXT
Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods
Am. J. Psychiatry 1998;155:1661-1670.
ABSTRACT
| FULL TEXT
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
Marino et al.
Proc. Natl. Acad. Sci. USA 1998;95:11465-11470.
ABSTRACT
| FULL TEXT
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam and Adams
Science 1998;281:1349-1352.
ABSTRACT
| FULL TEXT
Protein Kinase C and A3 Adenosine Receptor Activation Inhibit Presynaptic Metabotropic Glutamate Receptor (mGluR) Function and Uncouple mGluRs from GTP-Binding Proteins
Macek et al.
J. Neurosci. 1998;18:6138-6146.
ABSTRACT
| FULL TEXT
Symptoms, Cognitive Functioning, and Adaptive Skills in Geriatric Patients With Lifelong Schizophrenia: A Comparison Across Treatment Sites
Harvey et al.
Am. J. Psychiatry 1998;155:1080-1086.
ABSTRACT
| FULL TEXT
Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine
Adams and Moghaddam
J. Neurosci. 1998;18:5545-5554.
ABSTRACT
| FULL TEXT
Differentiation of Glycine Antagonist Sites of N-Methyl-D-aspartate Receptor Subtypes. PREFERENTIAL INTERACTION OF CGP 61594 WITH NR1/2B RECEPTORS
Honer et al.
J. Biol. Chem. 1998;273:11158-11163.
ABSTRACT
| FULL TEXT
A Follow-up Magnetic Resonance Imaging Study of Schizophrenia: Relationship of Neuroanatomical Changes to Clinical and Neurobehavioral Measures
Gur et al.
Arch Gen Psychiatry 1998;55:145-152.
ABSTRACT
| FULL TEXT
Clozapine and Haloperidol Modulate N-Methyl-D-aspartate- and Non-N-Methyl-D-aspartate Receptor-Mediated Neurotransmission in Rat Prefrontal Cortical Neurons In Vitro
Arvanov et al.
J. Pharmacol. Exp. Ther. 1997;283:226-234.
ABSTRACT
| FULL TEXT
